Status:
RECRUITING
Prandial Metabolic Phenotype in Adults
Lead Sponsor:
Texas A&M University
Conditions:
Protein Metabolism
Eligibility:
All Genders
60-80 years
Phase:
NA
Brief Summary
Previous studies suggest that changes in metabolism due to the effects of aging might serve as a potential for therapeutic agents. The investigating lab developed a pulse method combining multiple sta...
Detailed Description
The study involves 1 screening visits of approximately 3 hours and 6 study days of approximately 8 hours. Subjects will be asked to arrive in the fasted state on all study days. Fasting prior to scre...
Eligibility Criteria
Inclusion
- Age: 60-80, inclusive
- Stable body-weight (± 5%) for the past 3 months
- Subject is judged to be in satisfactory health based on medical history, physical examination, and laboratory screening evaluations.
- Ability to walk, sit down and stand up independently or with walking mobility aids
- Ability to lie in supine or elevated position for up to 7 hours
- Willingness and ability to comply with the protocol
Exclusion
- Established diagnosis of current malignancy
- History of untreated metabolic diseases including hepatic or renal disorder
- Presence of acute illness or metabolically unstable chronic illness
- Presence of fever within the last 3 days
- Use of short course of oral corticosteroids within 4 weeks preceding study day
- (Possible) pregnancy
- Failure to give informed consent or Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements
- Already enrolled in another clinical trial and that clinical trial interferes with participating in this study
- Any other condition according to the PI or nurse that was found during the screening visit, that would interfere with the study or safety of the patient
Key Trial Info
Start Date :
June 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05400733
Start Date
June 24 2022
End Date
September 1 2026
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Human Clinical Research Facility
College Station, Texas, United States, 77843